1. Home
  2. SAMG vs CGEN Comparison

SAMG vs CGEN Comparison

Compare SAMG & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • CGEN
  • Stock Information
  • Founded
  • SAMG 2002
  • CGEN 1993
  • Country
  • SAMG United States
  • CGEN Israel
  • Employees
  • SAMG N/A
  • CGEN N/A
  • Industry
  • SAMG Investment Managers
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SAMG Finance
  • CGEN Health Care
  • Exchange
  • SAMG Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • SAMG 149.2M
  • CGEN 135.6M
  • IPO Year
  • SAMG 2013
  • CGEN 2000
  • Fundamental
  • Price
  • SAMG $14.78
  • CGEN $1.47
  • Analyst Decision
  • SAMG
  • CGEN Strong Buy
  • Analyst Count
  • SAMG 0
  • CGEN 1
  • Target Price
  • SAMG N/A
  • CGEN $4.00
  • AVG Volume (30 Days)
  • SAMG 72.9K
  • CGEN 268.4K
  • Earning Date
  • SAMG 05-01-2025
  • CGEN 05-19-2025
  • Dividend Yield
  • SAMG 5.40%
  • CGEN N/A
  • EPS Growth
  • SAMG 4.17
  • CGEN N/A
  • EPS
  • SAMG 1.00
  • CGEN N/A
  • Revenue
  • SAMG $123,651,000.00
  • CGEN $27,864,000.00
  • Revenue This Year
  • SAMG $9.70
  • CGEN $11.81
  • Revenue Next Year
  • SAMG $7.28
  • CGEN $28.37
  • P/E Ratio
  • SAMG $14.78
  • CGEN N/A
  • Revenue Growth
  • SAMG 5.32
  • CGEN N/A
  • 52 Week Low
  • SAMG $14.12
  • CGEN $1.13
  • 52 Week High
  • SAMG $19.20
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 32.30
  • CGEN 49.50
  • Support Level
  • SAMG $14.26
  • CGEN $1.13
  • Resistance Level
  • SAMG $15.92
  • CGEN $1.35
  • Average True Range (ATR)
  • SAMG 0.70
  • CGEN 0.11
  • MACD
  • SAMG -0.01
  • CGEN 0.03
  • Stochastic Oscillator
  • SAMG 22.13
  • CGEN 85.00

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: